ZIPSCRIPT

Serial Number 98610161
Registration 7766517
700

Registration Progress

Application Filed
Jun 20, 2024
Under Examination
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered
Apr 22, 2025

Trademark Image

ZIPSCRIPT

Basic Information

Serial Number
98610161
Registration Number
7766517
Filing Date
June 20, 2024
Registration Date
April 22, 2025
Published for Opposition
March 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 22, 2025
Registration
Registered
Classes
001 005

Rights Holder

QIAGEN Beverly, LLC

16
Address
100 Cummings Center, Suite 407J
Beverly, MA 01915

Ownership History

QIAGEN Beverly, LLC

Original Applicant
16
Beverly, MA

QIAGEN Beverly, LLC

Owner at Publication
16
Beverly, MA

QIAGEN Beverly, LLC

Original Registrant
16
Beverly, MA

Legal Representation

Attorney
Randolph E. Digges, III

USPTO Deadlines

Next Deadline
1901 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Apr 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 11, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 11, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 11, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 11, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 23, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 23, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 23, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 20, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning
First Use Anywhere: Nov 9, 2017
First Use in Commerce: Nov 9, 2017
Class 005
Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes
First Use Anywhere: Nov 9, 2017
First Use in Commerce: Nov 9, 2017

Additional Information

Pseudo Mark
ZIP SCRIPT

Classification

International Classes
001 005